Cargando…
The emerging role of circular RNAs in drug resistance of non-small cell lung cancer
Due to the characteristics of aggressiveness and high risk of postoperative recurrence, non-small cell lung cancer (NSCLC) is a serious hazard to human health, accounting for 85% of all lung cancer cases. Drug therapies, including chemotherapy, targeted therapy and immunotherapy, are effective treat...
Autores principales: | Yan, Tinghao, Tian, Xinchen, Liu, Fen, Liu, Qingbin, Sheng, Qing, Wu, Jianlin, Jiang, Shulong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9592927/ https://www.ncbi.nlm.nih.gov/pubmed/36303840 http://dx.doi.org/10.3389/fonc.2022.1003230 |
Ejemplares similares
-
Emerging Roles of Non-proteolytic Ubiquitination in Tumorigenesis
por: Yin, Xiu, et al.
Publicado: (2022) -
Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: Mechanistic insights
por: Tian, Xinchen, et al.
Publicado: (2022) -
The Role of Circular RNAs in the Drug Resistance of Cancers
por: Liu, Xin-Yuan, et al.
Publicado: (2022) -
Emerging Role of Circular RNAs in Cancer
por: Liu, Jing, et al.
Publicado: (2020) -
Insights into the role of nucleotide methylation in metabolic-associated fatty liver disease
por: Zhang, Ni, et al.
Publicado: (2023)